Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18-Methoxycoronaridine in Cutaneous Leishmaniasis
NCT03084952Phase 2Unknown
- Sponsor
- Infinant Health
- Start
- May 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of 18-methoxycoronaridine in cutaneous leishmaniasis (CL), sponsored by Infinant Health. Status: unknown.
02
Drugs
18-methoxycoronaridine
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT03084952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03084952.